PCM
CYTK icon

Pinz Capital Management’s Cytokinetics CYTK Stock Holding History

Pinz Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$20K – 199
2021
Q2 		$20K Sell
1,000
-3,700
-79% -$86.9K 0.01% 359
2021
Q1 		$109K Buy
+4,700
New +$100K 0.03% 199

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Pinz Capital Management's CYTK Position: Q3 2021 in Review

Pinz Capital Management sold out of Cytokinetics (CYTK) in Q3 2021, closing a stake of 1,000 shares — an estimated $20K sold.

Pinz Capital Management first reported a position in CYTK in Q1 2021 and held it in 2 quarters. The position peaked at $109K in Q1 2021. 211 funds tracked by Wall St. Rank hold CYTK as of Q3 2021.

  • Pinz Capital Management reported no remaining Cytokinetics position as of Q3 2021 after selling out during the quarter.
  • Pinz Capital Management sold 1,000 Cytokinetics shares in Q3 2021, an estimated $20K.
  • Pinz Capital Management first reported a position in Cytokinetics in Q1 2021 and held it in 2 quarters.
  • Pinz Capital Management's Cytokinetics position peaked at $109K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.